What podcasts say about Kevin Weil

Every statement, with the speaker, the exact quote and the moment it was said.

What Kevin Weil has said on podcasts

11 statements · 9 positive · 1 negative · 1 neutral

on robotic laboratoriesPositiveOct 22, 2026· TBPN
Robotic laboratories will accelerate scientific research.
“robotics and robotic labs are going to accelerate science”
Listen at 47:48
Open the episode · Matthew Prince on PHP2Shell, iPhone Duo Early Reactions, Meta Unveils New Class C Stock | Matthew Prince, Kevin Weil, MC Lader, Dillon Baxter, Richard Starson, Brian Manning
on robotic laboratoriesPositiveOct 22, 2026· TBPN
Robotic labs can generate large-scale data for training scientific AI models.
“these kind of labs can generate data at huge scale to train amazing AI models for science.”
Listen at 47:57
Open the episode · Matthew Prince on PHP2Shell, iPhone Duo Early Reactions, Meta Unveils New Class C Stock | Matthew Prince, Kevin Weil, MC Lader, Dillon Baxter, Richard Starson, Brian Manning
on U.S. pharmaceutical researchPositiveOct 22, 2026· TBPN
The United States should reshore pharmaceutical scientific capabilities from China.
“we need to reshore scientific capabilities from China”
Listen at 48:04
Open the episode · Matthew Prince on PHP2Shell, iPhone Duo Early Reactions, Meta Unveils New Class C Stock | Matthew Prince, Kevin Weil, MC Lader, Dillon Baxter, Richard Starson, Brian Manning
on pharmaceutical developmentNeutralOct 22, 2026· TBPN
Almost all pharmaceutical pipelines include substantial work performed in China.
“almost all of them had big parts of their programs that happened in China.”
Listen at 49:00
Open the episode · Matthew Prince on PHP2Shell, iPhone Duo Early Reactions, Meta Unveils New Class C Stock | Matthew Prince, Kevin Weil, MC Lader, Dillon Baxter, Richard Starson, Brian Manning
on U.S. drug developmentPositiveOct 22, 2026· TBPN
The United States should retain domestic drug-development capabilities.
“We don't want to lose the ability to turn ideas into medicines here in the United States.”
Listen at 50:33
Open the episode · Matthew Prince on PHP2Shell, iPhone Duo Early Reactions, Meta Unveils New Class C Stock | Matthew Prince, Kevin Weil, MC Lader, Dillon Baxter, Richard Starson, Brian Manning
on drug-molecule optimizationNegativeOct 22, 2026· TBPN
Drug-molecule optimization commonly takes three to five years and is outsourced to China.
“there's this like three to five year process and that entire process is outsourced to China.”
Listen at 52:03
Open the episode · Matthew Prince on PHP2Shell, iPhone Duo Early Reactions, Meta Unveils New Class C Stock | Matthew Prince, Kevin Weil, MC Lader, Dillon Baxter, Richard Starson, Brian Manning
on U.S. pharmaceutical contract researchPositiveOct 22, 2026· TBPN
The U.S. pharmaceutical contract-research market is large and growing.
“there's not just a big market today. There's a big and growing market going forward.”
Listen at 53:29
Open the episode · Matthew Prince on PHP2Shell, iPhone Duo Early Reactions, Meta Unveils New Class C Stock | Matthew Prince, Kevin Weil, MC Lader, Dillon Baxter, Richard Starson, Brian Manning
on laboratory roboticsPositiveOct 22, 2026· TBPN
Laboratory robotics is still early in its adoption S-curve.
“robotics is just at the beginning of the S-curve”
Listen at 54:03
Open the episode · Matthew Prince on PHP2Shell, iPhone Duo Early Reactions, Meta Unveils New Class C Stock | Matthew Prince, Kevin Weil, MC Lader, Dillon Baxter, Richard Starson, Brian Manning
on robotic pharmaceutical laboratoriesPositiveOct 22, 2026· TBPN
Robotic labs can reshore pharmaceutical research and generate data for advanced scientific AI.
“we need to reshore this from China, and this is the way that you generate data at scale that will allow us to build the next generation of incredible scientific AI models.”
Listen at 55:54
Open the episode · Matthew Prince on PHP2Shell, iPhone Duo Early Reactions, Meta Unveils New Class C Stock | Matthew Prince, Kevin Weil, MC Lader, Dillon Baxter, Richard Starson, Brian Manning
on AI-designed drugsPositiveOct 22, 2026· TBPN
AI-designed drug development will create demand for substantially more physical drug testing.
“the thing that's going to come when AI is able to develop and to design more drugs is then we're going to need to test way more drugs.”
Listen at 56:28
Open the episode · Matthew Prince on PHP2Shell, iPhone Duo Early Reactions, Meta Unveils New Class C Stock | Matthew Prince, Kevin Weil, MC Lader, Dillon Baxter, Richard Starson, Brian Manning
on Warp SciencesPositiveOct 22, 2026· TBPN
Warp should build its automated CRO from scratch rather than retrofit an existing one.
“I think you just need to build from scratch with the idea that you're looking to automate this from day one”
Listen at 57:34
Open the episode · Matthew Prince on PHP2Shell, iPhone Duo Early Reactions, Meta Unveils New Class C Stock | Matthew Prince, Kevin Weil, MC Lader, Dillon Baxter, Richard Starson, Brian Manning

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.